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Aims The coronary collateral circulation as an alternative source of blood supply has shown benefits regarding several clini-
cal endpoints in patients with myocardial infarction (MI) such as infarct size and left ventricular remodelling. However,
its impact on hard endpoints such as mortality and its impact in patients with stable coronary artery disease (CAD) is
more controversial. The purpose of this systematic review and meta-analysis was to explore the impact of collateral
circulation on all-cause mortality.
Methods
and results
We searched MEDLINE, EMBASE, ISI Web of Science (2001 to 25 April 2011), and conference proceedings for
studies evaluating the effect of coronary collaterals on mortality. Random-effect models were used to calculate
summary risk ratios (RR). A total of 12 studies enrolling 6529 participants were included in this analysis. Patients
with high collateralization showed a reduced mortality compared with those with low collateralization [RR 0.64
(95% confidence interval 0.45–0.91); P ¼ 0.012]. The RR for ‘high collateralization’ in patients with stable CAD
was 0.59 [0.39–0.89], P ¼ 0.012, in patients with subacute MI it was 0.53 [0.15–1.92]; P ¼ 0.335, and for patients
with acute MI it was 0.63 [0.29–1.39]; P ¼ 0.257.
Conclusions In patients with CAD, the coronary collateralization has a relevant protective effect. Patients with a high collateraliza-
tion have a 36% reduced mortality risk compared with patients with low collateralization.
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Background
The concept that coronary arteries are pure end arteries has been
disproved years ago.1 The coronary collateral circulation (CCC)
connects epicardial coronary arteries and is present in patients
with and without coronary artery disease (CAD).2,3 These collat-
eral arteries have the potential to remodel and expand in case
of an epicardial coronary artery stenosis, providing an alternative
source of blood supply to jeopardized myocardium. In patients
with ST elevation infarctions, a relevant protective role of collat-
erals has been observed regarding smaller infarct size, preservation
of cardiac function after acute infarctions, reduction in post-infarct
ventricular dilatation, and regarding post-infarct aneurysm for-
mation.3 However, the general impact of the CCC on mortality
is less clear.3
The purpose of this systematic review and meta-analysis was to
integrate all available data in order to assess the impact of the CCC
on mortality in patients with stable or acute CAD.
Methods
The study was performed according to the MOOSE (meta-analysis of
observational studies in epidemiology) guidelines. Planning and study
design was done by three authors (C.S., P.M., and B.P.), including cre-
ation of an electronic database with variables of interest (Microsoft
EXCEL). Endpoints, variables of interest, and search strategy (data-
bases, sources for unpublished data) were defined in a strategy
outline (see Supplementary material online, File 1). No language
restriction was applied.
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Search strategy
We searched EMBASE, PubMed, BIOS, and ISI Web of Science from
1980 through 25 April 2011. In addition, abstract lists and conference
proceedings from the 2006 to 2010 scientific meetings of the Ameri-
can College of Cardiology, the European Society of Cardiology, the
symposium on Transcatheter Cardiovascular Therapeutics of the
American Heart Association, and the World Congress of Cardiology
were searched. We also considered published review articles, edi-
torials, and internet-based sources of information (www.tctmd.com,
www.theheart.org, www.europcronline.com, www.cardiosource.com,
and www.crtonline.com) to assess potential information on studies
of interest. Reference lists of selected articles were reviewed for
other potentially relevant citations. Authors of selected studies were
contacted to obtain further information if needed. All prospective
studies reporting on an association between mortality and CCC
were included in this analysis. Retrospective case–control studies
were not eligible. The detailed search syntax for the database
Medline is shown in Supplementary material online, Table S1. The
syntax for other databases was similar but was adapted where necess-
ary. In brief, search terms included ‘collateral circulation’, ‘survival’,
‘prognosis’, and ‘mortality’.
Study selection
In a two-step selection process, the titles and abstracts of all citations
were reviewed to identify potentially relevant studies. Selection of
abstracts was by agreement of two investigators (C.S. and P.M.). In a
second step, the corresponding publications were reviewed in full
text to assess whether studies met the following inclusion criteria:
association of mortality and the degree of coronary collateralization
(Figure 1). Selection of manuscripts was again by agreement of two
investigators (C.S. and P.M.).
Data extraction and quality assessment
Relevant information from the articles, including baseline clinical
characteristics of the study population and outcome measures, were
extracted using the prepared standardized extraction database. The
quality of each study was assessed with the Newcastle-Ottawa Scale
(NOS)4 (see Supplementary material online, Table S2). Absolute
numbers were recalculated when percentages were reported. These
steps were performed independently by two investigators (P.M., C.S.).
Endpoint
The primary endpoint of this analysis was all-cause mortality. However,
the study of Regieli et al. only presented cardiovascular mortality and
these data were used instead.5
Definitions
Good collateralization was defined differently in the individual studies.
Most studies performed a visual assessment (Rentrop score)6 and used
a score of ≤1 for low collateralization (no or only faintly visible collat-
erals). Four studies dichotomized their patients into ‘no collaterals
visible’ (Rentrop 0) vs. ‘any collaterals visible’ (Rentrop 1–3).5,7–9
One study based the collateral quantification on intra-coronary
pressure measurements (collateral flow index, CFI)10 (Table 1) and
defined low collateralization as a CFI of ,0.25.11 The CFI was
measured with a pressure-sensor tipped coronary guidewire which is
placed distal to the coronary artery stenosis. In the presence of myo-
cardial infarction (MI), ‘acute’ was defined as angiography within
,12 h, ‘subacute’ as MI within 2–28 days.
Data synthesis and analysis
Data of included studies were combined to estimate the pooled impact
(risk ratio, RR) of good collateralization vs. low collateralization. Calcu-
lations were based on a DerSirmonian and Laird random-effects
model.12 Continuity correction was used when no event occurred in
one group to allow calculation of an RR.13 Heterogeneity among
trials was quantified with Higgins’ and Thompson’s I2. I2 can be inter-
preted as the percentage of variability due to heterogeneity between
studies rather than sampling error. An I2 . 50% is considered as an
at least moderate heterogeneity. All results are presented as point esti-
mates and corresponding 95% CIs in brackets.
To assess the effect of individual studies on the summary estimate of
effect, we performed an influence analysis using a jackknife procedure;
pooled estimates were recalculated by omitting one study at a time.
Figure 1 Study selection process.
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We assessed publication bias visually (funnel plot) and by formal tests
(rank order correlation test and Egger’s test of intercept).14,15 To
assess the impact of continuous (duration of follow-up, year of publi-
cation) and categorical moderator variables (study setting; type of
intervention, method of collateral assessment) on the described
effect of collaterals on survival, a mixed-effects model was used.
If only in-hospital outcomes were available, a median follow-up dur-
ation of 5 days was assumed. The follow-up intervals (unit: months)
were log-transformed for this analysis. All analyses were performed
independently by two investigators (P.M. and G.K.) using R, version
2.10.1 (package ‘meta’ and ‘metafor’).16
Results
Description of included studies
A total of 123 articles were reviewed and 12 studies were
included that satisfied the predetermined inclusion criteria
(Figure 1).5,7 –9,17–24 Table 1 summarizes the characteristics of the
included studies.
Mortality
Patients with a high collateralization showed a significantly reduced
mortality risk compared with patients with low collateralization,
RR 0.64 (95% confidence interval 0.45–0.91), P ¼ 0.012 (Figure 2).
Subset analyses
The study setting did not have a significant impact on the rela-
tive risk estimates. For stable CAD, the RR for ‘high collaterali-
zation’ was 0.59 [0.39 – 0.089]; P ¼ 0.012. For those with
subacute MI, the RR was 0.53 [0.15–1.92], P ¼ 0.335. For par-
ticipants presenting with an acute MI, the RR for high vs. low
collateralization was 0.63 [0.29–1.39], P ¼ 0.257 (Figure 3).
These differences in RR were not statistically significant (inter-
action P-value ¼ 0.149).
However, the beneficial effect of collaterals was more pro-
nounced in studies where most patients underwent PCI (RR 0.42
[0.32–0.56]; P, 0.001) compared with studies without PCI (RR
0.70 [0.51–0.97]; P ¼ 0.035). In the one study where patients
underwent thrombolysis,19 those with high collateralization had
increased mortality (RR 1.82 [1.12–2.96]; P ¼ 0.015). (Figure 4)
These differences in RR were statistically significant (P for inter-
action ,0.001).
The predictive role of collaterals was significant for the 11
studies which used visual assessment for collaterals (RR 0.71
[0.50–0.99]; P ¼ 0.045) and even more pronounced in one
study which measured collaterals via CFI (RR 0.38 [0.26–0.56];
P, 0.001).17 This RR difference was significant (P for inter-
action ¼ 0.015).
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Helfant 1971 Visual Elective 22.9 No High CCC na na na
Low CCC na na na
Williams 1976 Visual Subcute MI In-hospital No High CCC 51.0 20 na
Low CCC 58.4 17 na
Nestico 1985 Visual Elective 34 No High CCC 56.0 35 98
Low CCC 58.0 50 74
Hansen 1989 Visual Elective 120 No High CCC 49.2 10 na
Low CCC 47.9 7 na
Perez-Castellano 1999 Visual Acute MI In-hospital No High CCC 64.0 18 na
Low CCC 64.0 18 na
Nicolau 1999 Visual Acute MI 36.4 Thrombolysis High CCC na na na
Low CCC na na na
Antioniucci 2002 Visual Acute MI 6 Yes High CCC 63 18 na
Low CCC 64 23 na
Monteiro 2003 Visual Acute MI 15.7 Yes High CCC 63.3 11 na
Low CCC 65.3 10 na
Meier 2007 CFI Elective 120 Yes High CCC 61.0 21 69
Low CCC 62.0 24 59
Regieli 2009 Visual Elective 24 Yes High CCC 57.0 na na
Low CCC 56.0 na na
Desch 2009 Visual Acute MI 6 Yes High CCC 64.0 26 na
Low CCC 66.0 24 na
Steg 2010 Visual Subacute MI 60 50% PCI High CCC 58.4 23 na
Low CCC 60.4 20 na
CFI, collateral flow index (intra-coronary wedge-pressure derived collateral assessment); high CCC, high coronary collateralization; low CCC, low collateralization; na, not
available; PCI, percutaneous coronary intervention.
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Figure 2 Forest plot of risk ratios for mortality. CCC, coronary collateral circulation; CI, confidence interval. Markers represent point esti-
mates of risk ratios; marker size represents study weight in random-effect meta-analysis. Horizontal bars indicate 95% confidence intervals.
Figure 3 Forest plot of risk ratios for mortality risk, stratified by clinical setting (stable CAD, vs. subacute MI, vs. acute MI). CAD, coronary
artery disease; CCC, coronary collateral circulation; CI, confidence interval; MI, myocardial infarction; Horizontal bars indicate 95% confidence
intervals.
Collaterals and mortality 617
Effect of moderator variables
There was no effect of the year of publication on the reported
effect of collaterals on survival (regression coefficient 20.003
[20.038 to 0.033]; P ¼ 0.891) nor had the duration of follow-up
any significant effect (regression coefficient 0.073 [20.076 to
0.222]; P ¼ 0.339).
Sensitivity analyses
The jackknife procedure-based sensitivity analysis omitting one
study at a time showed consistent estimates for the relative risk
reduction in patients with high collateralization. None of the
studies influenced the overall result towards statistical non-
significance (Figure 5).
The funnel plot was rather symmetrical (Figure 6), formal
testing did not indicate a relevant ‘small study effect’ or publi-
cation bias (Egger’s test P ¼ 0.677, rank correlation test
P ¼ 0.641). However, even under imputation of potentially
unpublished studies with the Trim and Fill method, the overall
result was not relevantly changed with an overall RR of 0.65
[0.47–0.91]; P ¼ 0.013 (imputed study RR 3.26 [0.219–48.37]).
Discussion
This meta-analysis of 12 studies and 6529 patients shows that the
CCC is associated with relevantly improved survival. The result
was consistent whether patients underwent PCI or a diagnostic
angiogram only, and whether collaterals were assessed visually or
with CFI. Subgroup analyses indicate a clearly prolonged survival
of well-collateralized patients with stable CAD while the analyses
for subacute and acute CAD show comparable risk reductions
which did not reach statistical significance; this is mainly due to a
smaller sample size (limited statistical power) with wider
confidence intervals.
Potential mechanisms of survival benefit
of coronary collaterals
The exact underlying mechanism for the protective role of collat-
erals is unclear. We know that acute myocardial ischaemia leads to
QT interval prolongation, which puts the patient at risk for fatal
arrhythmias.25 The collateral circulation can reduce such QT
prolongation during vessel occlusion and this may contribute to
the reduced mortality in patients with a well-developed CCC.25
The collateral circulation has also demonstrated clinical benefit
Figure 4 Forest plot of risk ratios for mortality risk, stratified by type of intervention (PCI, no PCI, and thrombolysis). CAD, coronary artery
disease; CCC, coronary collateral circulation; CI, confidence interval; MI, myocardial infarction. Horizontal bars indicate 95% confidence
intervals.
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regarding smaller infarct size, preservation of cardiac function after
acute infarctions, and reduction in post-infarct ventricular dilata-
tion.26 Over the long term, these effects are likely to contribute
to a reduced mortality.
Potential clinical implications
The coronary collaterals may represent a useful prognostic marker.
Patients with a low collateralization have an increased mortality
risk and may be monitored more closely. Diagnostic angiography
in patients with suspected CAD remains important to define the
coronary anatomy and the degree of collateralization. This is opti-
mally being done by measuring the CFI while the Rentrop score is
easier and cheaper to assess but has significant limitations.27 Alter-
natively, an intracoronary ECG could be used as an objective and
simple method. ST-segment elevation of 0.1 mV during a 1-min
balloon occlusion detects ischaemia and low collateralization28
and it has demonstrated to predict mortality.17
Further, the results of this study highlight the importance of
finding means to induce collateral growth. Several experimental
studies and first clinical studies have demonstrated that it is poss-
ible to promote arteriogenesis with the growth factors GM-CSF,
G-CSF, or with external counterpulsation.3,29,30,31 However,
these studies have demonstrated that promoting collateral
growth is feasible but the studies were too small to evaluate
whether this improvement in collateral function translates into
improved survival.
Heterogeneity among included studies
Several aspects contribute to this heterogeneity. The most impor-
tant one is the difference in study populations. Studies included
Figure 5 Influence analysis with forest plot of risk ratios for mortality. Each line represents a re-analysis of the data with exclusion of one
study (inclusion of 11 studies only) at a time to assess the influence of this particular study on the overall result.
Figure 6 Funnel plot of the estimates of relative risk vs. standard error. SE, standard error. Lower standard errors indicate better precision
and larger study size.
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patients with stable CAD while other studies focused on patients
with acute MI (Table 1). Further, some studies treated patients with
PCI,5,11,18,21,22 others with thrombolysis or only with medical
therapy8,9,19,20,23,24 or had a diagnostic and a PCI arm.7 Only one
study used CFI-based collateral assessment while all the others
studies used visual assessment of collaterals. Visual assessment is
not a very accurate method to quantify coronary collateralization
and the studies used variable threshold to dichotomize the
groups.27
Limitations of this meta-analysis
First, all included studies have specific and general limitations. All
studies were observational. A causal relationship between well-
developed coronary collaterals and improved survival is hypotheti-
cal and cannot be proven without an interventional study design. A
high coronary collateralization may simply represent a marker
which is associated with better survival. However, the main deter-
minant of collateralization is the degree of coronary stenosis.
Therefore, a high collateralization is more likely to be present in
patients with an extensive CAD. Two of the included studies
reported on diameter stenosis degree which was clearly higher
in the group with high collateralization (Table 1).32 Nevertheless,
this group showed improved survival in our analysis.
Another draw-back is that most studies were rather small, the
smallest study enrolled only 20 patients. Few studies were
protocol-driven, most were retrospective analyses of registries
or trials and, therefore, the primary objective was often quite
different in the underlying primary studies. All but one studies
used exclusively binary data for their analysis. The extent of vari-
able of interest, collateralization, was dichotomized into ‘high’
and ‘low collateralization’ while in fact, the degree of collateraliza-
tion is a continuous variable.
This analysis does not capture the dynamic of the coronary col-
laterals. The coronary collateral function has been demonstrated
to decrease over a 6-month period after PCI.33 This dynamic
may explain the non-significant results in the setting of acute MI.
During an acute vessel occlusion, the collaterals undergo rapid
changes, a fact that limits the value of a single time-point measure-
ment. Further, the increased left ventricular end-diastolic pressure
during an acute MI impairs the accuracy of the collateral
assessment.34
For two studies, absolute numbers of events were back-
calculated from percentages which were based on Kaplan–Meier
event estimates.19,23 This can be erroneous, especially if a signifi-
cant number of patients are lost to follow-up. It was not possible
to verify these data with the authors of the original publication.
However, these two studies had a maximum of two patients lost
to follow-up. All included studies had very low drop-out rates in
general, the highest rates were 5%.8,25
Outlook
Future research should prospectively assess the effect of coronary
collaterals on clinical outcomes. Such studies should be strictly
protocol driven with a clearly pre-defined primary endpoint such
as mortality and where the collateralization is assessed with CFI
or other quantitative measurements rather than with a visual
assessment. Future studies should carefully control for possible
confounding factors which has to include factors that influence
the collateralization (stenosis degree) and factors that influence
the outcome (mortality) such as age, gender, type of intervention,
and co-morbidities. Such studies also have to be adequately
powered to detect a difference in mortality. We further need
larger scale interventional studies which test whether the thera-
peutic promotion of collaterals translates into improved clinical
outcomes.
Conclusions
The results of this meta-analysis demonstrate that an high coronary
collateralization indicates a reduced mortality risk. The assessment
of the coronary collateralization provides useful information for
the risk assessment of patients with CAD undergoing coronary
angiography. The therapeutic induction of collateral growth may
have significant implications on outcomes.
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Supplementary material is available at European Heart Journal
online.
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